These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 400825)

  • 21. [Comparison of the antibacterial effects of ofloxacin, oxolinic acid and nalidixic acid].
    Langsádl L; Menkyna R; Golier J; Silan L
    Cesk Epidemiol Mikrobiol Imunol; 1988 Sep; 37(5):297-308. PubMed ID: 3197127
    [No Abstract]   [Full Text] [Related]  

  • 22. Bactericidal effect against Escherichia coli of nalidixic acid and four structurally related compounds.
    Stevens PJ
    J Antimicrob Chemother; 1980 Jul; 6(4):535-42. PubMed ID: 6159344
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of flumequine on the resistance of the coliform flora of chickens to the agent.
    Hinton M; Linton AH
    J Vet Pharmacol Ther; 1985 Dec; 8(4):393-7. PubMed ID: 4094029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro action of oxolinic acid in comparison with nitrofurantoin and nalidixic acid].
    Grima P
    Minerva Urol; 1977; 29(5):225-7. PubMed ID: 611403
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of derivatives of 3-quinolinecarboxylic acid on DNA synthesis, growth and division in Escherichia coli 15 TAU.
    Sulcová V; Hanová J; Capek A; Vondrejs V
    Folia Microbiol (Praha); 1974; 19(4):281-91. PubMed ID: 4606488
    [No Abstract]   [Full Text] [Related]  

  • 26. Automated analysis of oxolinic acid and flumequine in salmon whole blood and plasma using dialysis combined with trace enrichment as on-line sample preparation for high-performance liquid chromatography.
    Agasøster T; Rasmussen KE
    J Chromatogr; 1991 Mar; 564(1):171-9. PubMed ID: 1860911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of six quinolone antibacterials (author's transl)].
    Soussy CJ; Thibault M; Kitzis MD; Acar JF; Duval J; Chabbert YA
    Ann Microbiol (Paris); 1977 Jul; 128B(1):19-33. PubMed ID: 907268
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
    Barry AL; Jones RN; Thornsberry C; Ayers LW; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1984 May; 25(5):633-7. PubMed ID: 6233935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mode of action of a new nalidixic acid derivative, AB206.
    Nagate T; Komatsu T; Izawa A; Ohmura S; Namiki S; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 May; 17(5):763-9. PubMed ID: 6156644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absorption, tissue distribution and excretion of flumequine and oxolinic acid in corkwing wrasse (Symphodus melops) following a single intraperitoneal injection or bath treatment.
    Samuelsen OB; Ervik A
    J Vet Pharmacol Ther; 2001 Apr; 24(2):111-6. PubMed ID: 11442785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative single-dose pharmacokinetics of four quinolones, oxolinic acid, flumequine, sarafloxacin, and enrofloxacin, in Atlantic salmon (Salmo salar) held in seawater at 10 degrees C.
    Martinsen B; Horsberg TE
    Antimicrob Agents Chemother; 1995 May; 39(5):1059-64. PubMed ID: 7625789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-performance liquid chromatographic determination of oxolinic acid and flumequine in the live fish feed artemia.
    Touraki M; Ladoukakis M; Prokopiou C
    J Chromatogr B Biomed Sci Appl; 2001 Feb; 751(2):247-56. PubMed ID: 11236080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of the in vitro activity of enoxacin on bacterial strains recently isolated in a hospital milieu].
    Lembo M; Nani E; Covelli I; Amato G; Lavitola A
    G Batteriol Virol Immunol; 1985; 78(7-12):205-16. PubMed ID: 3870425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penicillin-binding proteins of filaments of Escherichia coli induced by low concentrations of nalidixic acid, oxolinic acid, novobiocin or nitrofurantoin.
    Amaral L; Schwarz U; Lorian V
    Drugs Exp Clin Res; 1986; 12(8):653-6. PubMed ID: 3530676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Minimal inhibitory concentration in hospital bacteria].
    Marcenac FM; Fernández AJ; Rebollo MN; Helou HT; Civalero TR; Herran IL; Magri MA
    Rev Asoc Argent Microbiol; 1974; 6(2):44-61. PubMed ID: 4467221
    [No Abstract]   [Full Text] [Related]  

  • 36. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
    Barry AL; Jones RN
    Antimicrob Agents Chemother; 1984 Jun; 25(6):775-7. PubMed ID: 6234858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ionization and divalent cation dissociation constants of nalidixic and oxolinic acids.
    Timmers K; Sternglanz R
    Bioinorg Chem; 1978 Aug; 9(2):145-55. PubMed ID: 698279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo antibacterial activity of AB206, a new naphthyridine derivative.
    Nagate T; Kurashige S; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Feb; 17(2):203-8. PubMed ID: 7387143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The assessment of antimicrobial activity in an in-vitro model of the treatment of bacterial cystitis.
    Greenwood D
    J Antimicrob Chemother; 1984 May; 13 Suppl B():43-8. PubMed ID: 6234274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cooking on residues of the quinolones oxolinic acid and flumequine in fish.
    Steffenak I; Hormazabal V; Yndestad M
    Acta Vet Scand; 1994; 35(3):299-301. PubMed ID: 7847199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.